These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18172353)

  • 21. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies.
    Hisamatsu T; Ueno F; Matsumoto T; Kobayashi K; Koganei K; Kunisaki R; Hirai F; Nagahori M; Matsushita M; Kobayashi K; Kishimoto M; Takeno M; Tanaka M; Inoue N; Hibi T
    J Gastroenterol; 2014 Jan; 49(1):156-62. PubMed ID: 23955155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.
    Rotondo C; Lopalco G; Iannone F; Vitale A; Talarico R; Galeazzi M; Lapadula G; Cantarini L
    Mediators Inflamm; 2015; 2015():451675. PubMed ID: 26185360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide in Behçet's disease.
    Shek LP; Lim DL
    Biomed Pharmacother; 2002 Feb; 56(1):31-5. PubMed ID: 11908493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behçet's disease.
    Yesudian PD; Edirisinghe DN; O'Mahony C
    Int J STD AIDS; 2007 Apr; 18(4):221-7. PubMed ID: 17509169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.
    Li Y; Han Z; Wang X; Mo Z; Zhang W; Li A; Liu S
    BMC Gastroenterol; 2013 Dec; 13():167. PubMed ID: 24321021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical course of intestinal Behcet's disease during the first five years.
    Jung YS; Cheon JH; Park SJ; Hong SP; Kim TI; Kim WH
    Dig Dis Sci; 2013 Feb; 58(2):496-503. PubMed ID: 22899244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current therapy for Behçet's disease.
    Goker B; Goker H
    Am J Ther; 2002; 9(5):465-70. PubMed ID: 12237740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study.
    Han M; Jung YS; Kim WH; Cheon JH; Park S
    J Gastroenterol; 2017 Aug; 52(8):920-928. PubMed ID: 28028610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two patients with childhood-onset Behcet's disease successfully treated by anti-tumor necrosis factor therapy].
    Kaneko U; Kishi T; Kikuchi M; Hara R; Shinoki T; Miyamae T; Imagawa T; Mori M; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(3):157-61. PubMed ID: 20601837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
    Andonopoulos AP; Meimaris N; Daoussis D; Bounas A; Yiannopoulos G
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S57-8. PubMed ID: 14727465
    [No Abstract]   [Full Text] [Related]  

  • 32. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of intestinal Behçet's disease.
    Hisamatsu T; Naganuma M; Matsuoka K; Kanai T
    Clin J Gastroenterol; 2014 Jun; 7(3):205-12. PubMed ID: 24883128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diffuse ulcerative lesions in the colon with intestinal Behçet's disease].
    Mori S; Tokutomi K; Kawamura H; Takeuchi A; Hashimoto T
    Ryumachi; 1989 Jun; 29(3):172-7. PubMed ID: 2814706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Crohn disease and ulcerative colitis - current status: internal medicine aspects].
    Ewe K; Karbach U
    Chirurg; 1981 Dec; 52(12):744-8. PubMed ID: 6119189
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical response to thalidomide and colchicine in two siblings with Behcet's disease carrying a single mutated MEFV allele.
    Rigante D; La Torre F; Calcagno G; Falcini F
    Rheumatol Int; 2012 Jun; 32(6):1859-60. PubMed ID: 21833519
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term clinical outcomes of intestinal Behçet's disease: A 30-year cohort study at a tertiary hospital in South Korea.
    Park J; Park SJ; Park JJ; Kim TI; Cheon JH
    J Gastroenterol Hepatol; 2023 Mar; 38(3):386-392. PubMed ID: 36346041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of apremilast for 3 months in Behçet's disease: A prospective observational study.
    Hirahara L; Kirino Y; Soejima Y; Takeno M; Takase-Minegishi K; Yoshimi R; Takeuchi M; Mizuki N; Nakajima H
    Mod Rheumatol; 2021 Jul; 31(4):856-861. PubMed ID: 32996801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Behçet's disease.
    Bang D
    Yonsei Med J; 1997 Dec; 38(6):401-10. PubMed ID: 9509910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Hirano T; Ohguro N; Hohki S; Hagihara K; Shima Y; Narazaki M; Ogata A; Yoshizaki K; Kumanogoh A; Kishimoto T; Tanaka T
    Mod Rheumatol; 2012 Apr; 22(2):298-302. PubMed ID: 21748365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.